1. Hicks L, Bartoces M, Roberts R, Suda K, Hunkler R, Taylor TJ, et al. US outpatient antibiotic prescribing variation according to geography, patient population, and provider specialty in 2011. Clinical Infectious Disease. 2015;60(9):1308-16.
2. Butler CC, Gillespie D, White P, Bates J, Lowe R, Thomas-Jones E, et al. C-Reactive Protein Testing to Guide Antibiotic Prescribing for COPD Exacerbations. New England Journal of Medicine. 2019;2019(381):111-20.
3. Global Initiative for Chronic Obstructive Lung Disease. Global Strategy for the Diagnosis, Management, and Prevention of COPD. In: Global Initiative for Chronic Obstructive Lung Disease, editor. Pocket Guide to COPD Diagnosis, Management, and Prevention. Global Initiative for Chronic Obstructive Lung Disease. 2019. p. 2.
4. Global Initiative for Chronic Obstructive Lung Disease. Management of Exacerbations. In: Disease, GIfCOL, editor. Pocket Guide to COPD Diagnosis, Management, and Prevention. Global Initiative for Chronic Obstructive Lung Disease. 2019. p. 38.
5. Llor C, Bjerrum L, Munck A, Hansen M, Cordoba G, Strandberg E, et al. Predictors for antibiotic prescribing in patients with exacerbations of COPD in general practice. Therapeutic Advances in Respiratory Disease. 2013;7(3):131-7.
6. Van Velzen P, Ter Riet G, Bresser P, Baars J, van den Berg B, van den Berg J, et al. Doxycycline for outpatient-treated acute exacerbations of COPD: a randomised double-blind placebo-controlled trial. Lancet Respiratory Medicine. 2017;5(6):492-9.
7. Anthonisen N, Manfreda J, Warren C, Hershfield E, Harding G, Nelson N. Antibiotic Therapy in Exacerbations of Chronic Obstructive Pulmonary Disease. Annals of internal medicine. 1987;106(2):196-204.
8. Minnaard MC, van de Pol AC, de Groot JA, De Wit NJ, Hopstaken RM, van Delft S, et al. The Added Diagnostic Value of Five Different C-reactive Protein Point-Of-Care Test Devices in Detecting Pneumonia in Primary Care: A Nested Case-Control Study. Scandinavian Journal of Clinical Laboratory Investigation. 2015;75(4):291-5.
9. Leuzzi G, Galeone C, Taverna F, Suatoni P, Morelli D, Pastorino U. C-reactive protein level predicts mortality in COPD: a systematic review and meta-analysis. European Respiratory Review. 2017;2017(26):160070.
10. Llor C, Moragas a, Hernandez S, Bayona C, Miravitlles M. Efficacy of Antibiotic Therapy for Acute Exacerbations of Mild to Moderate Chronic Obstructive Pulmonary Disease. American Journal of Respiratory and Critical Care Medicine. 2012;186(8):716-23.
11. Mathioudakis AG, Janner J, Moberg M, Alonso-Coello P, Vestbo J. A systematic evaluation of the diagnostic criteria for COPD and exacerbations used in randomised controlled trials on the management of COPD exacerbations. ERJ Open Res. 2019 Nov 15;5(4):00136-2019. doi: 10.1183/23120541.00136-2019. PMID: 31754621; PMCID: PMC6856493.